ImmuPharma licenses lupus drug Lupuzor to Avion in the United States

British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, a first-in-class treatment for auto-immune disease Lupus, with U.S. company Avion Pharmaceuticals.

from Reuters: Health News https://ift.tt/35GhPdF